Cypress Point Wealth Management’s iShares iBonds Dec 2028 Term Muni Bond ETF IBMQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06M Hold
119,536
0.62% 25
2026
Q1
$3.05M Hold
119,536
0.66% 23
2025
Q4
$3.06M Hold
119,536
0.67% 20
2025
Q3
$3.06M Hold
119,536
0.62% 20
2025
Q2
$3.04M Hold
119,536
0.74% 19
2025
Q1
$3.02M Hold
119,536
0.96% 19
2024
Q4
$3.01M Buy
119,536
+930
+0.8% +$23.6K 0.94% 19
2024
Q3
$3.04M Buy
118,606
+688
+0.6% +$17.4K 1.19% 21
2024
Q2
$2.95M Buy
117,918
+687
+0.6% +$17.2K 1.4% 17
2024
Q1
$2.96M Buy
117,231
+231
+0.2% +$5.87K 1.52% 15
2023
Q4
$2.99M Buy
+117,000
New +$2.91M 2.22% 14

Other funds holding IBMQ

Cypress Point Wealth Management's IBMQ Position: Q2 2026 in Review

Cypress Point Wealth Management held its iShares iBonds Dec 2028 Term Muni Bond ETF (IBMQ) position steady in Q2 2026 at 119,536 shares worth $3.06M. The position accounts for 0.62% of the portfolio, ranked #25.

Cypress Point Wealth Management first reported a position in IBMQ in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.06M in Q3 2025. 197 funds tracked by Wall St. Rank hold IBMQ as of Q2 2026.

  • Cypress Point Wealth Management held 119,536 shares of iShares iBonds Dec 2028 Term Muni Bond ETF worth $3.06M as of Q2 2026.
  • Cypress Point Wealth Management left its iShares iBonds Dec 2028 Term Muni Bond ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2028 Term Muni Bond ETF made up 0.62% of Cypress Point Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Cypress Point Wealth Management first reported a position in iShares iBonds Dec 2028 Term Muni Bond ETF in Q4 2023 and has held it in 11 quarters since.
  • Cypress Point Wealth Management's iShares iBonds Dec 2028 Term Muni Bond ETF position peaked at $3.06M in Q3 2025.
  • 197 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Muni Bond ETF as of Q2 2026.

Based on Cypress Point Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.